Through crowdfunding, Chinese insurtech firm Waterdrop makes treatment for critical diseases accessible to the majority of China's population who have no commercial health insurance.
Why
Critical disease treatments expensive
Critical disease and cancer treatments are too expensive for Chinese citizens without commercial health insurance.
Costly traditional insurance plans
With human agents as middlemen, traditional insurance plans tend to be expensive.
Market
26.1%
Projected percentage of China’s life/health insurance premiums from online channels by 2024, growing from 6% in 2019 at a CAGR of 26.1%: iResearch.
The rest of the content is only available if you are logged in.
